Steve Fuller
Impact in
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Nicotinic Acetylcholine Receptors Study 2
-
- Pneumonia and Respiratory Infections 2
- Co-authors
- Gary Horwith (3 shared papers)Robert Naso (3 shared papers)Ali Fattom (3 shared papers)Larry R. Muenz (2 shared papers)Rachel Schneerson (1 shared paper)Juan Antonio Ordóñez Pereda (1 shared paper)Steven Black (1 shared paper)Harry Alcorn (1 shared paper)
- Journals
- Vaccine (3 papers)Journal of Clinical Microbiology (2 papers)Neurobiology of Aging (2 papers)Cancer Letters (1 paper)Clinical Chemistry (1 paper)
- Partner nations
- United StatesVietnamCameroon
In The Last Decade
Steve Fuller
19 papers receiving 845 citations
Peers
Comparison fields: 5 of 87
- Infectious Diseases 419
- Microbiology 124
- Clinical Biochemistry 78
- Molecular Medicine 46
- Endocrinology 32
Countries citing papers authored by Steve Fuller
This map shows the geographic impact of Steve Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Fuller more than expected).
Fields of papers citing papers by Steve Fuller
This network shows the impact of papers produced by Steve Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Fuller. The network helps show where Steve Fuller may publish in the future.
Co-authors
The 25 scholars most cited alongside Steve Fuller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 355 | |
| 2 | 2003 | 133 | |
| 3 | 2004 | 74 | |
| 4 | 1994 | 65 | |
| 5 | 2005 | 61 | |
| 6 | 1993 | 40 | |
| 7 | 2017 | 36 | |
| 8 | 1983 | 22 | |
| 9 | 2019 | 19 | |
| 10 | 1992 | 18 | |
| 11 | 1988 | 17 | |
| 12 | 1989 | 9 | |
| 13 | 1985 | 9 | |
| 14 | 2021 | 5 | |
| 15 | An accelerated enzyme immunoassay for human choriogonadotropin in urine, involving reflow of specimen through capillary tubes. | 1987 | 5 |
| 16 | 1987 | 4 | |
| 17 | 1996 | 3 | |
| 18 | 2018 | 2 | |
| 19 | Studies on inhibition of β-amyloid formation in APP-751-transfected IMR-32 cells, and SPA4CT-transfected SHSY5Y cells | 1997 | 2 |
| 20 | 1996 | 0 |
About Steve Fuller
Steve Fuller is a scholar working on Molecular Biology, Epidemiology, Radiology, Nuclear Medicine and Imaging, Infectious Diseases and Physiology, having authored 20 papers that have together received 879 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pneumonia and Respiratory Infections (2 papers), Nicotinic Acetylcholine Receptors Study (2 papers), Syphilis Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), Adolescent and Pediatric Healthcare (1 paper) and Alzheimer's disease research and treatments (1 paper). The work is most often cited by research in Infectious Diseases (419 citations), Microbiology (124 citations), Clinical Biochemistry (78 citations), Molecular Medicine (46 citations) and Endocrinology (32 citations). Steve Fuller has collaborated with scholars based in United States, Vietnam and Cameroon. Frequent co-authors include Gary Horwith, Robert Naso, Ali Fattom, Larry R. Muenz, Rachel Schneerson, Juan Antonio Ordóñez Pereda, Steven Black, Harry Alcorn, John B. Robbins and Henry R. Shinefield. Their work appears in journals such as Vaccine, Journal of Clinical Microbiology, Neurobiology of Aging, Cancer Letters and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.